Over the past decade or so there has been much research on Adult Stem Cells (ASC) and the use of Aphanizomenon Flos-Aquae (AFA) and their application to various diseases.
Proliferation– When stem cells reach the site of an injury they must proliferate and expand, as there are not enough Peripheral blood stem cells (PBSC) to accomplish full repair of any significant injury or degenerative process.
AFA has been proven to trigger a mild but significant increase in the number of PBSC, but its safety allows for a sustained oral daily consumption over long periods of time, allowing for safe daily release and to enhance proliferation of bone marrow stem cells (BMSC), which will migrate to cells in need in the body.
Clinical applications using SE-
CASE 4.1- Parkinson
MC is a 62 yr male with a 17-year history of Parkinson’s Disease.
MC was initially diagnosed with Parkinson’s type resting pill-rolling tremor affecting his left hand and then progressing to the limbs on left side of his body.
Over the course of five years the tremors increased gradually affecting the right side as well. At ten years into the disease process, MC was no longer able to practice as an attorney, mobility was affected and limitations increased compromising his personal and professional abilities.
In 2009, before the treatment of SE, the left side tremors had significantly worsened, symptoms of stiffness and bradykinesia which introduced a shuffling gait and poor balance made it unsafe for him to ambulate without the use of a cane.
At the time MC began consuming SE he was unable to dress himself, put on his watch, write, feed himself or drive his car.
After 45 days on the product, consuming 1 gram of SE, three times per day, MC showed significant improvement with decreased tremors, less stiffening and bradykinesia; at this time MC was able to get around without the use of his cane.
After 60 days on the product, judging that the benefits had plateaued, MC discontinued the use of SE. Forty-five days later, signs of tremor and bradykinesia returned and MC was seeking medical attention, once again. MC resumed SE with a dose of 2 grams, three times per day and within six weeks showed much improvement with less tremors, stiffness and bradykinesia.
MC was able to participate in activities of daily living, such as dressing and feeding himself, he was also able to tie his own tie, put on his watch, and once again, he could ambulate without using a cane.
To date MC has been on SE for two years, he has returned to driving his car without limitations, he is independent with all activities of daily living and he also participates in some level of professional activity.
Another patient-
MT, is a 52yr old woman with an early onset of Parkinson at age 36, with tremor as the primary symptom. Early treatment consisted of Pergolid, then Budipin up to 30 mg three times a day. However due to QTc increase, Budipin was later reduced to 10 mg three times a day.
One year ago, MT began consuming StemEnhance 1 gram three times a day. Today MT’s experiences only minor tremor accompanied with some dyskinetic syndrome and sometimes propulsion.
Her quality of life has increased and she is much more socially active.
Click to see more Science
Click to buy yours or to read more about StemEnhance Ultra